Antimicrobial resistance of Staphylococcus spp. from human specimens submitted to diagnostic laboratories in South Africa, 2012–2017

dc.contributor.authorSigudu, Themba Titus
dc.contributor.authorOguttu, James Wabwire
dc.contributor.authorQekwana, Daniel N.
dc.contributor.emailnenene.qekwana@up.ac.zaen_US
dc.date.accessioned2025-02-17T07:41:21Z
dc.date.available2025-02-17T07:41:21Z
dc.date.issued2024-09-09
dc.descriptionDATA AVAILABILITY STATEMENT : The data supporting this study’s findings are available upon reasonable request and subject to specific conditions. For data access inquiries, including requests for collaboration or data-sharing agreements, please contact Thomas Papo, data analyst, at thomas.papo@nhls.ac.za. Requests will be evaluated on a case-by-case basis, considering the request’s nature, compliance with relevant regulations, and any associated agreements or protocols.en_US
dc.description.abstractAntimicrobial resistance (AMR) poses a significant worldwide health challenge associated with prolonged illnesses, increased healthcare costs, and high mortality rates. The present study examined the patterns and predictors of AMR among human Staphylococcus isolates obtained from diagnostic laboratories in South Africa between 2012 and 2017. This study examined data from 404 217 isolates, assessing resistance rates across different characteristics such as age, sample origin, Staphylococcus species, and study period. The highest resistance was observed against cloxacillin (70.3%), while the lowest resistance was against Colistin (0.1%). A significant (p < 0.05) decreasing trend in AMR was observed over the study period, while a significant increasing temporal trend (p < 0.05) was observed for multidrug resistance (MDR) over the same period. A significant (p < 0.05) association was observed between specimen type, species of organism, and year of isolation with AMR outcome. Significant (p < 0.05) associations were observed between specimen type and season with MDR. The observed high levels of AMR and a growing trend in MDR are concerning for public health. Clinicians should take these findings into account when deciding on therapeutic options. Continued monitoring of AMR among Staphylococcus spp. and judicious use of antimicrobials in human medicine should be promoted.en_US
dc.description.departmentParaclinical Sciencesen_US
dc.description.librarianam2024en_US
dc.description.sdgSDG-03:Good heatlh and well-beingen_US
dc.description.urihttps://www.mdpi.com/journal/microorganismsen_US
dc.identifier.citationSigudu, T.T.; Oguttu, J.W.; Qekwana, D.N. Antimicrobial Resistance of Staphylococcus spp. from Human Specimens Submitted to Diagnostic Laboratories in South Africa, 2012–2017. Microorganisms 2024, 12, 1862. https://DOI.org/10.3390/microorganisms12091862.en_US
dc.identifier.issn2076-2607
dc.identifier.other10.3390/microorganisms12091862
dc.identifier.urihttp://hdl.handle.net/2263/100969
dc.language.isoenen_US
dc.publisherMDPIen_US
dc.rights© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.en_US
dc.subjectStaphylococcusen_US
dc.subjectIsolatesen_US
dc.subjectHumanen_US
dc.subjectSpeciesen_US
dc.subjectAntimicrobial resistance (AMR)en_US
dc.subjectMultidrug resistance (MDR)en_US
dc.subjectSouth Africa (SA)en_US
dc.subjectSDG-03: Good health and well-beingen_US
dc.titleAntimicrobial resistance of Staphylococcus spp. from human specimens submitted to diagnostic laboratories in South Africa, 2012–2017en_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Sigudu_Antimicrobial_2024.pdf
Size:
535.98 KB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: